WinSanTor's Unattributed Round

WinSanTor raised a round of funding on November 16, 2017.

WinSanTor is a clinical-stage biotechnology company focused on the discovery and development of treatments for peripheral neuropathies, including diabetic peripheral neuropathy, chemo-induced peripher…

Articles about WinSanTor's Unattributed Round: